ABOUT
Insight - Innovation - Access - Engagement - Partnering
The one summit which convenes a high level, by-invitation, boutique gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups in digital health, tech and A.I. for neurosciences and mental health. Addressing not only opportunities but also the core challenges facing companies and stakeholders. Sharing models, lessons learned, mistakes, solutions, ways forward and best practices. Fostering a unique level of sustained high-quality discussion, access, engagement and partnering in a truly curated summit unlike any other event.
VISION
Convening the full value chain to disrupt silos and curate highly interactive, multi-disciplinary, cross-industry, and multi-stakeholder discussions of opportunities, challenges, hurdles and ways forward.
Drive transformational connections, discussion and partnering for startups and growth companies.
Deliver insight, access, engagement and partnering to foster innovation and accelerate value creation.
Contribute to meaningful improvement in healthcare outcomes and positive impact for patients and society.
WHY NOW?
From A.I. enabled drug discovery and development, big data, digital biomarkers, Real World Data and trial design, to advanced imaging, companion digital health, cognitive behavioral therapy and connected health, to neuromodulation and V.R., the pace of innovation is unprecedented.
Paradigms are changing, and the potential for positive impact on patient outcomes and quality of life, improved delivery of care, healthcare expenditure, and societal benefit are enormous.
The Neuro, Digital & A.I. Innovation Summit is organized by Broadreach Global and Hosted by the Champalimaud Foundation, with Partners the European Brain Council (EBC), and the support of our Global Innovation Partners and other key stakeholder organizations.
The launch edition in 2022 delivered a unique, meaningful and high-impact initiative unlike other events. Join us in 2023.
ADVISORY BOARD
We are honored to introduce our advisory board: meet them in person at the summit.
 Joe PatonDirector of Neuroscience & Principal Investigator, Champalimaud Foundation |  Ana MaicquesCEO & Co-Founder, Neuroelectrics |  Paulo MachadoCEO/Founder - Health Innovation Partners, Angel - What if Ventures, Mentor - Amazon Web Services Healthcare Accelerator, Mentor - Texas Medical Center Innovation |  Pawel SwiebodaDirector General - Human Brain Project, and CEO - EBRAINS |
|---|---|---|---|
 Shwen GweeDigital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder |  Mark TreherneChairperson, Monument Therapeutics |  Harris Eyre MD PhDBrain Capital Builder, Lead - Brain Capital Alliance, Co lead - OECD Neuroscience-inspired Policy Initiative, Fellow - The Baker Institute for Public Policy, Senior Fellow - Meadows Mental Health Policy Institute |  Christian J. SuojanenFounder & CEO - Broadreach Global, Member of the Board - European Brain Foundation (EBF) |
 Naomi GloverCo-Founder/Director, Applied Neuroscience Association |  Fred DestrebecqExecutive Director, European Brain Council (EBC) |
SPEAKERS
Proudly convening leading speakers and stakeholders from across the sector
 Joachim ScholppGlobal Head Translational Medicine, CNS, Retinal Health & Emerging Areas - Boehringer Ingelheim |  John KrakauerProfessor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation - Johns Hopkins School of Medicine | Ana MaicquesCEO & Co-Founder - Neuroelectrics |  Steve CarnevaleCalifornian Mental Health Commissioner, Chairman - Sawgrass Technologies, Founder & Managing Director - Point Cypress Partners |
|---|---|---|---|
Pawel SwiebodaDirector General - Human Brain Project, and CEO - EBRAINS |  Pamela TanaertsChief Scientific Officer - Medable (or colleague) |  Edward KliphuisPartner - Sofinnova Partners |  Nick TaptiklisHead of Technology Strategy - Cambridge Cognition (to be confirmed) |
 David Braga MaltaLife Sciences Investor & Entrepreneur - PE Thematic Health, Pictet Bank |  Andy KellerPresident & CEO - Meadows Mental Health Policy Institute | Paulo MachadoCEO/Founder - Health Innovation Partners, Angel - What if Ventures, Mentor - Amazon Web Services Healthcare Accelerator, Mentor - Texas Medical Center Innovation |  Julia PrakapovichPartner - Interface Fund |
Mark TreherneChairperson - Monument Therapeutics |  Karl HessManaging Director - Outcome Capital |  Vreni SchoenenbergerGlobal Franchise Head, External Affairs /Partnership Strategy - Novartis (to be confirmed) |  Joshua HaynesFounder & Managing Partner - Masawa Fund |
Shwen GweeDigital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder | Naomi GloverCo-Founder/Director - Applied Neuroscience Association |  JP BorgesManaging Partner - JP Borges Abogados, Co-Founder - Exputnik Accelerator |  Hana BesbesInvestor - Heal Capital |
 Jason DictenbergInvestor, Executive Chairman - Evergreen Biosciences, Advisory Board Member - Alzheimer's Drug Discovery Foundation, Editor - CellR4 Journal on Regenerative Medicine |  Lorena Muñoz VivasCEO - Effectia Consulting |  Christian J. SuojanenCEO - Broadreach Global, Member of the Executive Board - European Brain Foundation |
WHO'S COMING?
Two days of sustained, interactive discussion, networking and partnering with:
Industry Leaders
Senior industry executives from pharma, digital health, technology & health providers & systems. Heads of therapeutic area, R&D, real world data, clinical development, digital health, scouting, business development & licensing.
Key Opinion Leaders
Key Opinion Leaders from all stakeholder groups at the confluence of neurosciences & mental health with digital, technology, data and A.I.
Founders & CEOs
From startup and growth companies at the confluence of neuroscience and mental health with digital, medtech, imaging, technology, data and A.I.
Government & NGOs
Public agencies, societies, associations & NGOs in brain health, neurology, neurosciences, psychiatry & mental health, patient organizations, economic development, health, research & innovation.
Investors
In CNS, neuroscience and mental health, data, health tech, digital health, A.I. and deeptech.
VC and corporate venture, private equity, family offices, angels & HNW.
Leading Advisors
A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants.
THEMES
Detailed program coming soon.
Topics and themes include:
Calling neuroscience, mental health, technology, data, digital health and A.I. innovation-leaders, decision-makers & KOLs, from all stakeholder groups; join in an open format, high-engagement, silo-bridging, cross industry, multi-disciplinary summit of interactive discussions on rising to both the challenges and the opportunities in brain health innovation:
-
The scope of the problem & unmet medical need
-
Dementia & neurodegeneration
-
Neuromuscular disorders
-
Rare diseases
-
Traumatic & non-traumatic brain injury
-
Mental health
-
Neurodiversity
-
Health equity
-
-
Data, Technology & A.I. in precision medicine & drug development
-
Digital twins
-
Real World Data & distributed, technology clinical trials
-
Digital biomarkers, surrogate & clinical end points
-
Digital delivery of care & C.B.T.
-
Advanced imaging
-
Monitoring, early detection & diagnosis
-
Wearables, sensors & connected health
-
Digital health
-
Gamification
-
Digital tools, medicines & therapeutics
-
-
Companion digital health or alternative (digital) care journey
-
Virtual reality
-
Neurostimulation
-
Deep brain implants & machine brain interface
Tackling issues and challenges including:
What treatment paradigms and business models hold real promise?
Where are the real challenges?
What is needed to define the way forward?
Regulatory & I.P. issues
Pricing & reimbursement
The startup journey, path to market & recurring pitfalls.
Health system compatibility.
Proof of Concept to workflow integration & first use case.
Market entry & penetration.
Partnering, licensing & collaboration.
Getting to scale.
VENUE
Champalimaud Foundation
Av. Brasília, 1400-038
Lisbon, Portugal
The Champalimaud Foundation carries out research in cutting-edge fields and strives to stimulate discoveries that benefit people, and to promote new standards of knowledge.
It is at the Champalimaud Centre for the Unknown, in Lisbon, that the Foundation develops its activity in the areas of neuroscience and cancer. This is done through both research programmes and the provision of clinical services of excellence. It also has an outreach programme to fight blindness.
To pursue its objectives in achieving significant scientific advances, the Champalimaud Foundation adopts a translational methodology, which establishes a direct link and interdependency between basic research and clinical activity. This is a fundamental part of the Foundation’s methodology.
Ultimately, the Champalimaud Foundation aims to promote the health and well-being of humankind by seeking to actively participate in the search for solutions that can alleviate the burden of disease on societies and individuals.
CO-ORGANIZED WITH
ASSOCIATION PARTNER
HOST PARTNER
ASSOCIATION PARTNERS
STRATEGIC PARTNERS
GET IN TOUCH
Reach us here if you like to
-
Nominate a speaker
-
Apply to present your company or technology
-
Enquire about sponsorship & exhibition opportunities
Be the first to know
Subscribe and be among the first to receive all updates, announcements and invitations.
Please make sure to double check your email address.
A Broadreach Global Initiative
Contact us at:
Follow us
